ALNY - Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years | Benzinga
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 1.77% on an annualized basis producing an average annual return of 14.93%. Currently, Alnylam Pharmaceuticals has a market capitalization of $18.95 billion.
Buying $100 In ALNY: If ...